Subject: TRTC Enhances Shareholder Value Through Stronger Corporate Governance

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
TRTC Enhances Shareholder Value Through Stronger Corporate Governance
Hot Stock to WatchHot Stock to Watch


Company: Terra Tech Corp (OTCQX: TRTC)


End of Day:

Price: 0.13

Change (%): - 0.0001 (0.08)

Volume: 2,550,648
TRTC Chart

Terra Tech Corp. Strengthens Corporate Governance

Company takes key steps to improve compliance and enhance shareholder value to work toward its long-term goal of a NASDAQ up-listing

NEWPORT BEACH, Calif., Nov. 5, 2015 /PRNewswire/ - Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced that the Company’s Board of Directors (“the Board”) has initiated several enhancements to its corporate governance program to assist the Board in the exercise of its responsibilities to the Company and its stockholders.

“The adoption of these corporate governance policies is an important step in building a comprehensive and effective corporate compliance program,” said Derek Peterson, CEO of Terra Tech. “As we work toward our long-term goal of up-listing to the NASDAQ, we’re doing everything we can to ensure Terra Tech upholds the highest level of transparency, integrity and responsibility to stockholders.”

Continue Reading

Top PerformerYesterday's Top Performer

Company:
APPYEA Inc. (OTCQB: APYP)


End of Day:

Price: 0.0075

Change (%): + 0.0015 (25.00)

Volume: 4,274,996
APYP Chart

Recent News

AppYea Acquires 32 iOS & Amazon Apps Through Asset Purchase Agreement

FORT WORTH, Texas, Oct. 29, 2015 (GLOBE NEWSWIRE) - APPYEA (OTCQB:APYP) is pleased to announce the recent acquisition of 32 mobile applications. This new acquisition adds to the company’s current diversified app holdings. These new applications have been used by more than 8,000,000 user downloads. The apps cover a wide range of niche segments across iOS, Android, Amazon, and Kindle. The theme across the portfolio is strategy guides, video & text based tutorials, and other helpful content for popular games.

AppYea’s CEO Jackie Williams stated, “We’re very excited about this acquisition and what it’s going to do for our Company. We will continue working our business model and expand our app presence in the iOS Platform, Google Platform and the Amazon Platform.”

Continue Reading


Other Small Cap News


Company: mCig, Inc. (OTCQB: MCIG)


mCig, Inc. Provides Corporate Update

BEVERLY HILLS, CA--(Marketwired - Nov 5, 2015) - mCig, Inc. (the "Company") (OTCQB: MCIG), a leading distributor of innovative products, technologies, and services for the global medical and legal recreational cannabis industry, updates its shareholders on important progress made during the second quarter:

"We're very pleased with the excellent progress the company achieved during the last quarter. For the coming quarter and beyond, we remain excited by the many initiatives we have in place for all our brands and projects," said Paul Rosenberg, President and Chief Executive Officer of MCIG.

Continue Reading


Company: Implant Sciences Corporation (OTCQB: IMSC)


Implant Sciences to Announce First Quarter FY2016 Financial Results

Company to Report Q1 FY16 Sales Exceed FY15 Total Revenues

WILMINGTON, Mass., Nov. 5, 2015 /PRNewswire/ -- Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, will host a webcast and conference call on Thursday, November 12, 2015 at 4:15 p.m. to discuss the financial results for the first quarter of fiscal year 2016.

"We are excited about reporting this quarter's results. Implant Sciences' success, particularly in the European aviation market over the past six months, has led to the best year in the company's history as a manufacturer of explosives trace detection equipment," stated Dr. Bill McGann, CEO of Implant Sciences. "We entered into fiscal 2016 with a backlog of over 40 million dollars based upon our European aviation and TSA orders and I am happy to report that our Q1 sales will exceed our revenues for all of 2015."

Continue Reading


Company: Green Technology Solutions, Inc. (OTCBB: GTSO)


GTSO: Edibles Recall Highlights Need for Newer, Better Cannabis Solutions

SAN JOSE, Calif.--(BUSINESS WIRE)--As demand grows for greater precautions and regulations in the booming U.S. cannabis industry, products in Colorado were recalled this week due to contamination by potentially harmful pesticides used during cultivation. Green Technology Solutions, Inc. (OTCBB: GTSO) is working to market and develop new technologies to calm consumer anxieties and help avoid such costly recalls in the future.

Almost 30,000 packages of cannabis-infused edibles were recalled voluntarily in Colorado because independent tests found they contained potentially dangerous pesticides that are not approved for use on cannabis crops.

Continue Reading


Company: Aurora Cannabis Inc. (OTCQB: ACBFF)


Aurora Announces Exclusive Rights to Cannabis Inhaler

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 5, 2015) - Aurora Cannabis Inc. ("Aurora" or the "Company") (CSE:ACB) (OTCQB:ACBFF) (FRANKFURT:21P) (WKN:A1C4WM) is pleased to announce that it has entered into a letter of intent ("LOI") for exclusive distribution rights to Mystabis, a revolutionary inhaler that provides pressurized metered doses of cannabis.

The terms of the arrangement allow Aurora sole Canadian distribution of the device. The ability to administer metered doses is something that both patients and the medical community have been waiting for eagerly. Without the use of any form of heat or combustion, this pressurized inhaler ("pMDI") delivers exact quantities of cannabinoids in a manner that provides rapid medicinal effects while preserving the entourage effects of the cannabinoids and terpenoids. Physicians will find the delivery mechanism to be very familiar and will appreciate the precision controlled per dose delivery of both the THC and CBD dominant formulations.

Continue Reading


Market News


By CNBC.com staff: CNBC


Futures higher; jobs report in focus

U.S. stock index futures indicated a higher open on Thursday as traders looked to Friday's key employment report and reacted to comments on Wednesday from Fed Chair Janet Yellen, who reiterated the possibility of raising rates in December, given supportive data.

Another key central bank leader, New York Fed President William Dudley, separately told reporters Wednesday that he would "completely agree" with Yellen on a December hike.

While more Fed speakers are scheduled for Thursday - including Fed Vice Chair Stanley Fischer, the Philadelphia Fed's Patrick Harker and the Atlanta Fed President Dennis Lockhart - analysts said Yellen's comments and the forthcoming jobs report are most important.

Continue Reading


By Peter Schacknow:
CNBC


Early movers: TIME, FB, SEAS, TAP, VC, NDLS, INSY, QCOM, FEYE & more

Check out which companies are making headlines before the bell:

Time Inc. - Time beat estimates by 5 cents with adjusted quarterly profit of 32 cents per share, with revenue also above estimates. The magazine publisher continues to see a decline in print ad revenue, but that is being partially offset by an increase in digital ads. Separately, Time announced a deal to sell its principle British office building for 638 million dollars. The company also cut its guidance for the full year due to the ongoing shift to digital ads.

SeaWorld Entertainment - The theme park operator earned an adjusted $1.14 per share for its latest quarter, missing estimates by 4 cents, with revenue also falling short. SeaWorld points to weather-related park closures as a negative factor, along with higher legal costs and expenses related to "reputation initiatives," although it does say efforts to improve revenue and profits are taking hold.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks